3627 results for «414»

Filter By

3627 results

Featured research - Valves and beyond

26 Nov 2024 – From PCR London Valves 2024

This session features a selection of the latest research and insights from PCR London Valves 2024, covering a wide range of topics in valvular and structural heart interventions. Discover the early results of a new TTVR system, compare the performance of different TAVI devices, explore long-term...

Featured research - Valves and beyond

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....

Prof. Tian-Hai Koh

Chairperson

Tian Hai Koh
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli
AsiaPCR/SingLIVE 2017:

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul
AsiaPCR/SingLIVE 2017:

Four-Year Outcomes from the EVOLUT Low Risk Trial

26 Oct 2023

Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Dejan Milasinovic

Author

Dejan Milasinovic
Four-Year Outcomes from the EVOLUT Low Risk Trial

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial
Didn’t find what you were looking for?